. 2021 Feb 10;2021(2):CD012882. doi: 10.1002/14651858.CD012882.pub2

7. Comparison 1 results: coverage of appropriate treatment by an appropriate provider.

Outcome	Trial ID	Study design	Preintervention coverage		Postintervention coverage		Risk ratio (95% CI)
Outcome	Trial ID	Study design	iCCM	Control	iCCM	Control	Risk ratio (95% CI)
Coverage of appropriate treatment from an appropriate provider for any iCCM illness	Mubiru 2015 (diarrhoea)	CBA	2.2% 3/136	5.8% 11/191	16.1% 30/186	1.6% 3/188	10.11 (3.14 to 32.55)^a
	Mubiru 2015 (malaria)	CBA	32.4% 77/238	49.2% 184/374	64.1% 236/368	67.7% 342/505	0.95 (0.86 to 1.04)^a
	Yansaneh 2014 (diarrhoea)	CBA	31.6% 237/751	35.67% 237/664	52.2% 335/642	53.8% 394/733	0.97 (0.88 to 1.07)^a
	Yansaneh 2014 (malaria)	CBA	29.8% 581/1948	30.9% 562/1819	29.2% 412/1413	38.2% 712/1863	0.76 (0.69 to 0.84)^a
Coverage of appropriate treatment from an appropriate provider for diarrhoea	Mubiru 2015	CBA	2.2% 3/136	5.8% 11/191	16.1% 30/186	1.6% 3/188	10.11 (3.14 to 32.55)^a
	Yansaneh 2014	CBA	31.6% 237/751	35.67% 237/664	52.2% 335/642	53.8% 394/733	0.97 (0.88 to 1.07)^a
Coverage of appropriate treatment by an appropriate provider for malaria	Mubiru 2015	CBA	32.4% 77/238	49.2% 184/374	64.1% 236/368	67.7% 342/505	0.95 (0.86 to 1.04)^a
	Yansaneh 2014	CBA	29.8% 581/1948	30.9% 562/1819	29.2% 412/1413	38.2% 712/1863	0.76 (0.69 to 0.84)^a

CBA: controlled before‐after study; CI: confidence intervals; iCCM: integrated community case management. ^aWe recalculated results for Mubiru 2015 and Yansaneh 2014 based on unadjusted counts (see Data extraction and management).